Struggling with clinical data consistency? Explore how ADaM standardization across Phase II–IV studies enhances accuracy, compliance, and audit readiness.
Picture this: It’s 2 a.m. in the data programming war room. Your team is staring at three Phase III studies, two Phase II extensions, and a sprawling Phase IV registry, all feeding into the